Ivax Qvar pediatric approval
Executive Summary
Ivax' CFC-free asthma inhaler Qvar (beclomethasone) receives supplemental approval May 10 for use in children ages 5-11. FDA is reviewing whether Qvar will receive additional exclusivity with the pediatric approval. Ivax markets Qvar under an agreement with 3M (1"The Pink Sheet" April 8, In Brief)...